Mineralocorticoid receptor antagonist monotherapy in pediatric non-classical 11β-hydroxylase deficiency
CAH caused by 11βOHD is a known cause of hypertension. It is usually managed with glucocorticoids, and antihypertensives are added if blood pressure remains uncontrolled. In this case, glucocorticoid therapy was not tolerated and treatment with aldosterone antagonist monotherapy was effective in controlling his hypertension.
Authors
- Elaine Kennedy (ORCID: https://orcid.org/0000-0002-4610-701X)
- Colin P. Hawkes (ORCID: https://orcid.org/0000-0001-6484-0445)
- Maeve Durkan
- Caroline Joyce (ORCID: https://orcid.org/0000-0001-7231-8331)
- Eirin Carolan
- Maria Stack
Institutions
- University College Cork (IE)
- Bon Secours Hospital Cork (IE)
- Cork University Hospital (IE)
- Children's Health Ireland at Crumlin (IE)
- Infant (IE)
- University of Pennsylvania (US)
Publication Details
- Journal
- Journal of Pediatric Endocrinology and Metabolism
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1515/jpem-2024-0194
- Primary Topic
- Sexual Differentiation and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00